PTK2 and melanoma: Finally, we show that a small Pyk2 inhibitor reduced melanoma migration without enhancing invadopodia activity contrarily to a small FAK inhibitor that reduced only the migration process but enhanced matrix degradation via relocation of FA component to invadopodia [24].